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ABSTRACT 
 
 
 While there is evidence for a decline in olfactory identification scores for patients with 
Kidney Disease, there are contradictory results for detection thresholds. Some results indicate 
higher thresholds while others found similar thresholds or elevated thresholds for one odorant, 
but not others. The current study evaluated the olfactory abilities with participants diagnosed 
with Kidney Disease for numerous odorants. No significant differences were found in olfactory 
identification, detection thresholds, or sensitivity compared to healthy controls. Despite the non-
significant results, there did appear a trend of poorer olfactory abilities in Kidney Disease 
participants. The differences in olfactory performance also varied from odorant to odorant which 
indicates that a standardized set of odorants should be used when assessing threshold detection 
scores in the Kidney Disease population.   
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CHAPTER I 
INTRODUCTION
 
 
 Our olfactory abilities are a sense that most of us take for granted. At one point, our sense 
of smell was actually classified as a “lower” or “minor” sense (Blake & Sekuler, 2005). Such 
little attention is paid to the olfactory abilities that some individuals are not even aware that they 
lost their ability to smell (Landis, Hummel, Hugentobler, Giger, & Lacroix, 2003). 
Unfortunately, most people do not realize the importance of a normal sense of smell or that 
deficits in olfactory abilities can lead to issues in nutrition, quality of life, and psychological 
well-being (Doty, 2006). 
 Furthermore, most people are not educated in the various applications of olfactory 
functioning assessment. Assessments of olfactory abilities can allow for early detections of 
diseases and disorders as well as assist in differential diagnoses (Haehner, Hummel, & 
Reichmann, 2011; Rahayel, Frasnelli, & Joubert, 2012; Solomon, Petrie, Hart, & Brackin Jr, 
1998). Fortunately there has been an increase in the availability of olfactory tests for clinicians 
(Doty, 2006). These tests can be used to assess a wide variety of olfactory performance.  
There are several different assessments that can be used to measure olfactory abilities. 
Some of the more popular assessments are: Olfactory Identification (OI), Detection Thresholds 
(DT), Sensitivity, Odorant Discrimination, and Memory Tasks. For the purpose of this study, 
only OI, DT, and Sensitivity are discussed. 
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 One disease that is associated with of olfactory decline is Kidney Disease (KD), 
specifically, Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD). CKD is 
characterized by having kidney damage for three months or more. The disease can be broken into 
five stages (1-5), with a decrease in filtration rates from one stage to the next. Stage 5 of CKD 
and ESRD are both described as kidney failure, but differ in that ESRD requires chronic kidney 
dialysis (Bronnert, 2007). The incidence and prevalence of CKD has increased by 30% (Hallan 
& Vikse, 2008) and as of 2005, there were an estimated 1.9 million people suffering from ESRD 
(Grassmann, Gioberge, Moeller, & Brown, 2006). Like most illnesses, treatment can be very 
expensive which may deter people from seeking treatment and lead to prolonged symptoms 
(Hallan & Vikse, 2008). 
Frasnelli, Temmel, Quint, Oberbauer, and Hummel (2002) found that 56% of the patients 
in chronic renal failure had olfactory deficits. This becomes a serious issue given the impact 
olfactory abilities can have on quality of life and appreciation for food (Griep et al., 1997).  
Specifically, it was found that renal patients with the greatest olfactory dysfunction also are the 
most likely to become malnourished (Raff et al., 2008).  
While there is an association of olfactory deficits with KD, there is conflicting data. 
Some research indicates that those suffering from renal problems actually have normal olfactory 
functioning (Vreman, Venter, Leegwater, Oliver, & Weiner, 1980) while others depict some type 
of olfactory deficit (Griep et al., 1997). These results may actually be a result of the methods 
used to assess olfaction or a result of other symptoms associated with the disease.  
 There are variables other than diseases that can affect our sense of smell. Age and Gender 
are two of the more commonly known. There is a long history of anecdotal evidence suggesting 
that females are better smellers. More recently a significant amount of research has been 
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conducted to justify those claims (Good & Kopala, 2006). Moreover, certain physical and mental 
disorders can affect olfactory performance. In the CKD and ESRD population, for example, there 
is an increased risk of sleep disorders (Kimmel, Miller, & Mendelson, 1989; Pierratos & Hanly, 
2011). Depression is the most common psychiatric disorder in this population (Kimmel & 
Peterson, 2004; Kimmel, Weihs, & Peterson, 1993). These disorders will be discussed in the 
current study in the context of declines in olfactory performance with kidney disease.  
 
Olfactory Measures 
Since the mid to late 1980s, the number of easily administered measures for assessing 
olfaction has increased (Doty, 2006). These measures became generally available during the 
2000s (Doty, 2009). In addition, they allow for reliable measures of olfactory tasks and have 
many applications (Doty, 2006). It should be noted that most olfactory measures correlate 
positively with one another, but DTs correlate negatively with OI tasks (Doty, 2009). This 
negative correlation occurs because as one’s threshold increases, there is a decrease in the ability 
to detect odorants. This increased threshold accounts for the decrease in scores on OI tasks. 
 
Odorant Identification 
The assessment of OI has proven to be very reliable and has helped shape the current 
knowledge of human olfaction (Doty, 2006). A common way for measuring a person’s ability to 
identify an odorant is through the use of a microencapsulated odorant, or “scratch ‘n’ sniff” card 
(Blake & Sekuler, 2005). The University of Pennsylvania Smell Identification Test (Doty, 
Shaman, & Dann, 1984), a 40-item multiple forced choice smell test, is arguably the most 
popular and widely used assessment of OI (Doty, 2009). This test is administered by having a 
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participant scratch the surface of a “scratch and sniff” card, smell the odorant, and then decide 
which smell on a list of choices best represents the odorant. Even if the participant does not 
detect an odorant, or the choices provided do not match what the participant believes the odorant 
to be, a choice from the list must still be selected (Doty, 1995), which is referred to as a forced-
choice test. This test has been shown to be sensitive enough to distinguish variances in gender, 
smokers vs. nonsmokers, and ethnic groups (Doty et al., 1984). 
 Smell identification tests have been proven to be reliable. These tests can actually have 
only three questions and still have relatively high reliability and sensitivity (Duff, McCaffrey, & 
Solomon, 2002).  Reliability coefficients have been shown to be > .7 for multiple measures 
(Doty, Newhouse, & Azzalina, 1985). However, there is a positive relationship of reliability with 
the length of the test (Doty, 2006; Doty, Frye, & Agrawal, 1989). This relationship may occur as 
a result of the decreased probability of correctly guessing multiple odorants.  
 Given the sensitivity and reliability of the OI test, it has been used for diagnosing 
purposes. Solomon et al. (1998) were able to distinguish participants by either major depression 
or Alzheimer’s Disease (AD). The researchers discovered that the AD group performed 
significantly worse than the depressed group. Using similar methods, an olfactory measure was 
again used as a diagnostic tool to distinguish AD from vascular dementia (Duff et al., 2002).  
 
Detection Threshold 
The minimum amount of a stimulus (odorant, sound, light, etc.) needed in order to be 
detected is referred to as the DT (Møller, 2003). There are currently several methods for 
threshold task administration, but all present olfactory tasks follow the Ascending Method of 
Limits (AML) or Single Staircase (SS) methods (Doty, 2009). The AML procedure presents an 
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odorant at various levels, first with the lowest dilution presented followed by the next higher 
dilution and so forth. Two successive odorant detections determine the threshold. Other threshold 
tasks follow the same procedure, but then present the odorant dilutions in a descending fashion 
(thresholds determined from two successive non-detections) and average the two obtained 
thresholds (Doty, 2006). 
The SS procedure follows a similar basis as AML; except the dilutions are increased with 
a no detection response and dilutions are decreased with a detection response. After five 
reversals, the stimuli where the reversals occurred are averaged to obtain the threshold (Doty, 
2009). The more popular version of threshold tasks uses the staircase method and adds blanks (a 
stimulus that contains no odorant, also referred to as noise). Instead of presenting the blanks at a 
separate time, the blanks are presented with the odorant (again with various dilutions) and the 
participant is asked to pick (forced choice response similar to OI) which one contains the odorant 
(Doty, 2009; Landis et al., 2011). The reversals are dependent on whether or not the response 
was correct (dilutions increase with incorrect response and vice versa). The advantage of adding 
blanks is the control provided from those who may guess. For example, Suzuki et al. (2001) used 
a similar method to determine olfactory thresholds by increasing the dilution after an incorrect 
response, and then repeating the same stimuli after a correct response. After 5 correct responses, 
the dilution in the presented stimuli becomes the threshold.  
Unfortunately, there are limitations to the current methods of DTs, especially in 
reliability and validity (Doty, 2009). Doty (2006, 2009) recommends using a SS procedure for 
measuring DTs because of the increased reliability and stability. This increase is obtained by 
using reversals and presenting certain stimuli multiple times; more trials increase reliability and 
stability. However, this method still does not allow for every stimulus to be presented multiple 
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times. The stimuli presented are dependent on the participant’s responses. The location of 
reversals may be within a specific range which would never allow the participant to be presented 
the extended range of concentrations. To alleviate these problems, a new threshold test was 
developed to better align with other perceptual threshold tasks measuring vision and audition.   
The new measure created for obtaining olfactory DTs is called The Wheeler University 
of Tennessee at Chattanooga (WUTC) Threshold Test (Tewalt, 2013). The WUTC consists of 
not one, but five odorants and blanks. Vanillin, L-α-Pinene, Ethanol, Isoamyl Acetate (Banana), 
and P-cresol. P-cresol, a uremic toxin found in ESRD patients (Lin et al., 2011; Meijers et al., 
2010) with an odorant characterized as pig manure (Le, Aarnink, Ogink, Becker, & Verstegen, 
2005), was chosen to see if a build-up of this toxin in the blood system would affect the ability to 
detect the odorant. McKinney (2013) showed that there is no presence of P-cresol in the healthy 
population. Vanillin was chosen as it has a similar chemical structure to P-cresol. Banana has a 
chemical structure that is different from Vanillin, yet it has a similar sweet smell. L- α-Pinene 
and Ethanol do not have a sweet smell like Vanillin and Banana. None of the above odorants 
overstimulate the fifth trigeminal nerve (the cranial nerve that supplies somatic nerves to the 
nose). Stimulation of this nerve could cause a warm, sharp, or cool sensation (Hawkes & Doty, 
2009). 
The WUTC uses a slightly different method for obtaining the threshold through the use of 
the Method of Constant Stimuli (MCS) and Signal Detection Theory (SDT). While this 
methodology does differ slightly from existing methods used currently in detecting thresholds, 
SDT is broadly accepted by psychologists and is applied whenever two possible stimuli need to 
be discriminated from one another, or a stimulus needs to be detected, (Stanislaw & Todorov, 
1999). The methods discussed above are concerned with whether or not a participant detects an 
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odorant when the odorant is actually present although it is possible for a participant to say a 
stimulus was detected when in fact nothing was actually there. SDT was adapted to overcome 
this shortfall and accomplishes this through the use of “hits” and “false alarms” (Levine, 2000). 
The hit rate (H) is calculated by taking the proportion of “yes” responses to signal stimuli and the 
false alarm rate (F) is calculated by the proportion of “yes” responses to the blanks.   
As stated earlier, the SS method incorporates blanks where a participant has to 
distinguish between the stimuli and the blank. The difference in the methodology comes from the 
requirement of MCS to have the test present the stimuli multiple times in a random order (Blake 
& Sekuler, 2005). Note the SS procedure is not completely random, but instead relies upon the 
participant’s response (a correct or incorrect response dictates what will be presented next) and 
some individuals’ responses can generate shorter tests. When using AML or SS, it was actually 
possible for the participant to figure out what intensity to expect next. The MCS was specifically 
developed in order to alleviate these problems (Levine, 2000)  
The WUTC uses nine different dilutions for each odorant and nine blank stimuli. Each 
stimulus (both odorants and blanks) is presented one at a time to the participant in a random 
order twice, in which he or she is asked to respond with a “yes” or “no” as to whether or not an 
odorant was detected (Tewalt, 2013). A “yes” or “no” response is given for each presentation. By 
creating the dichotomous response from the participant for both the odorants and blanks, further 
methods can be used to assess other performance factors covered through SDT (Møller, 2003).  
In order to determine the thresholds for the various odorants, the yes/no responses to the 
odorant containing stimuli were analyzed using Logistic Regression. Through the Logistic 
Regression analysis, estimated probabilities are obtained for each concentration of an odorant. 
By graphing the relationship of the logarithmic concentration and probabilities with a sigmoid 
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curve, the concentration associated with a probability value of .5 becomes the estimated 
threshold (Tewalt, 2013). This method is identical to the general means of assessing auditory 
thresholds (Møller, 2003). See Figure 1.1 below for a graphical representation of obtaining the 
estimated threshold. 
 
 
Figure 1.1 Individual’s Predicted Probability vs. Vanillin Concentration 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added. 
The horizontal line depicts where the probability of .5 would intersect the probability curve. The 
vertical line was placed in the intersection to find the concentration for the threshold. The text box 
attached to the horizontal line depicts the threshold. 
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The logistic regression analysis also gives a B coefficient. This coefficient helps 
determine the size and direction in the probability of detecting the observed concentrations 
(Tabachnick & Fidell, 2013). In other words, the B coefficient indicates if the change in 
probabilities is a very sudden and sharp or more shallow and gradual. Moreover, the sign of the 
coefficient allows for any detection in response confusion and guessing. The B coefficients help 
identify any response confusion and determine if a change in concentrations for one odorant 
seems to have more of an impact than others odorants.  
 In addition to using a more reliable method for obtaining thresholds, the WUTC 
incorporates the use of blanks (but not in the fashion that blanks are used with the SS method). 
Instead, the blanks are individually presented randomly with all of the other odorant containing 
stimuli. This allows is for the participant to respond with a “yes” or “no” to the blanks 
themselves and can be used for manipulation checks. As stated earlier, the previous methods 
discussed force the participant to distinguish between an odorant containing stimuli and a blank. 
This does not tell us if the participant detected something in the blank (it is possible the 
participant thought they detected an odorant in both stimuli and guessed). The reason this new 
addition of a response to a blank is important because it also allows for further calculations to be 
made for Sensitivity through SDT.  
 
Sensitivity 
 Additional measures of olfactory performance can be assessed by using SDT in the 
WUTC. Specifically, the incorporation of a dichotomous response to each individual blank in 
addition to the odorants enables the WUTC to calculate sensitivity. Sensitivity is an individuals’ 
ability to discern a signal from noise (or an odorant from blanks) and can be calculated from hit 
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and false alarm rates (Stanislaw & Todorov, 1999). Although there is literature on olfactory 
sensitivity, it is actually being used interchangeably with DT. Specifically, most of this research 
refers to sensitivity as the inverse of DT. It may be counterintuitive to think of higher DT as 
poorer performance, so some researchers refer to thresholds as sensitivity.  
One method of calculating sensitivity is d’ (Miller, 1996). Sensitivity using d’ is 
calculated by obtaining the z scores for the hit and false alarm rates, and then subtracting the 
false alarm z score from the hit rate z score (Macmillan, 1993). This statistic can be affected by 
response bias which is the tendency for a participant to respond with “yes” or “no” which is why 
some researchers prefer a non-parametric measure of Sensitivity (Stanislaw & Todorov, 1999). 
Response bias can be computed through the nonparametric statistic Grier’s B’’ (Grier, 
1971). Ranges for B’’ can range from -1 to +1, with negative numbers indicating a bias towards 
responding with “yes” and a bias to responding with “no” indicated by positive numbers. The 
further away from 0 B’’ is, the greater the response bias. It seems counterintuitive to think of yes 
with a negative affect, so the present study will multiply a -1 to B’’ in order to flip the signs, 
resulting in positive numbers indicating a response bias of yes. The modified formula from 
(Stanislaw & Todorov, 1999) is as follows: 
 
     (    (   ))
( (   )   (   ))
 (   )   (   )
 
Note: H = Hit Rate and F = False Alarm Rate 
“sign(F – H)” equals +1 when F > H, 0 when F = H, and -1when F < H. 
 
By calculating response bias, it will allow for a determination of DT being skewed as a result 
response bias. 
Eq. 1.1 
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 Given that d’ can be affected by response bias; A’, a non-parametric statistic of sensitivity 
(Macmillan, 1993) is used. The formula for calculating A’ is as follows (Stanislaw & Todorov, 
1999): 
       [    (   )
(   )  |   |
    (   )     
] 
Note: H = Hit Rate and F = False Alarm Rate 
“max(H,F)” indicates using which ever value is larger. 
 
The ranges of A’ typically range from .5 – 1, with a value of .5 depicting no ability to distinguish 
stimuli from blanks. It should also be noted that absolute lowest possible value of A’ is 0, but 
any value lower than .5 is generally a result of error in sampling or response confusion 
(Stanislaw & Todorov, 1999).  
Sensitivity can be calculated for the entire test as well as for each individual odorant. This 
will give the test the ability to analyze if there are varying performances between the odorants for 
individual participants. This analysis is important because olfactory performance can vary 
between odorants (Good & Kopala, 2006). For example, Landis et al. (2011) found that when 
compared to healthy individuals, KD participants had elevated thresholds for one odorant, but 
normal thresholds in a different odorant. These multiple calculations for the entire WUTC and 
each individual odorant will help discern which specific odorants may be influenced by specific 
variables and which should be used when assessing the KD population. 
 
Variables Affecting Olfaction 
 Individuals vary in olfactory abilities and sensitivity. Some people are able to detect the 
faintest odorant from across the room while others struggle to find its source. There are several 
Eq. 1.2 
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variables affecting olfactory abilities, arguably the most notable being gender. As anecdotal 
evidence and research suggest, women outperform males on almost every olfactory task, (Good 
& Kopala, 2006).  
 Additionally, these gender effects can be made greater with age (Good & Kopala, 2006). 
The proportion of olfactory problems in the general population increases from 1-2% in those 
younger than 65 years of age to >50% in those older than 65 (Doty, 2006). While olfactory 
abilities do generally decrease with age, the decrease in performance is different for males and 
females. There is a decrease in OI abilities as age of participant increases. As expected, female 
performance is consistently greater than male performance, yet male performance begins to drop 
further below female performance at 50-59. Female decline is not as steady as male decline 
(Performance for both genders is similar at age 80-89, but females’ performance decreases less 
gradually) (Doty et al., 1984). Similar effects from age were found in other studies for DTs 
(Kobal et al., 2000). These differences in age may result from decreasing neurological activity 
with increasing age (Suzuki et al., 2001). 
While gender and age are common factors that affect olfactory abilities, other more 
complex issues can also hinder olfactory abilities. Fortunately, if these deficits are discovered 
early enough, they can be used to diagnosis underlying disease. For example, one of the earliest 
symptoms of both AD and Parkinson’s Disease (PD) is an impaired olfactory sense (Haehner et 
al., 2011; Rahayel et al., 2012). Olfactory tests have been used to be able to distinguish 
neurodegenerative diseases from other disorders that generate difficult differential diagnoses 
(Solomon et al., 1998). Even though there has been an increase in the number of easily 
administered clinical smell tests for many noted medical conditions (i.e. AD, PD, Depression, 
Sleep Disorders) (Doty, 2006), there has not been one developed for KD. 
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Kidney Disease 
One of the first studies to research olfaction in the KD population found that patients 
showed poorer performance on odorant discrimination tasks and rated odorants as more 
unpleasant when compared to healthy controls (Schiffman, Nash, & Dackis, 1978). Additionally, 
Corwin (1989) found that renal patients on dialysis had poor OI abilities compared to healthy 
controls. Raff et al. (2008) also found that participants diagnosed with ESRD had significantly 
lower OI scores than controls and that these olfactory deficits can lead to serious health issues 
like malnutrition (up to 75% of ESRD patients are malnourished) due to an inverse relationship 
between nutrition scores and OI scores. This olfactory deficit is thought to be the cause of the 
malnourishment (Landis et al., 2011). 
Treatment for KD patients can actually improve olfactory function. Landis et al. (2011) 
found after just one session of hemodialysis, OI performance was significantly improved. 
However, this result is temporary and the KD patients suffer from long term consequences of 
olfactory performance. If a patient receives a kidney transplant, his or her olfactory function 
returns to levels similar to the healthy population (Griep et al., 1997). Unfortunately, like any 
transplant, this treatment is complex and costly. However, the mechanisms responsible for these 
recoveries in olfactory performance are still unknown (Landis et al., 2011).  
While there is evidence for a decline in OI scores for patients in renal failure, there are 
contradictory results for DTs. These results vary greatly, both in the initial testing for 
comparisons and when measuring for treatment effects. The initial comparisons show the disease 
population to have either normal thresholds (Frasnelli et al., 2002; Vreman et al., 1980), have 
elevated thresholds (Griep et al., 1997), varied thresholds or an elevated threshold for one 
odorant but a normal one for another (Landis et al., 2011). Similarly, when looking for 
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improvements in olfaction after treatment, results show either no change in threshold (Griep et 
al., 1997), an improvement for thresholds (Korytowska & Szmeja, 1993), or an improvement in 
one odorant threshold but not a second odorant (Landis et al., 2011). 
Studies have shown that KD is associated with increased risks for depression (O’Donnell 
& Chung, 1997) and sleep disorders (Lüdemann, Zwernemann, & Lerchl, 2001; Unruh et al., 
2006). Each of these disorders also has associations with impaired olfactory performance, adding 
more confusion to olfactory impairment in KD patients. 
In addition to olfactory dysfunction, another symptom of renal failure is a significant 
reduction in normal nocturnal melatonin levels compared to healthy controls (Parker, 2003). This 
change may be the cause of the observation of day-night reversal in sleep patterns of dialysis 
patients (Parker, Bliwise, Bailey, & Rye, 2003). Over 50% of ESRD patients have sleep apnea 
(Kimmel et al., 1989; Unruh et al., 2006) compared to the 2-4% in the general population 
(Pierratos & Hanly, 2011).  
 Olfactory function has been shown to decrease with disturbances in Rapid Eye 
Movement (REM) sleep (Fantini, Postuma, Montplaisir, & Ferini-Strambi, 2006; Miyamoto et 
al., 2009; Postuma, Gagnon, Vendette, Desjardins, & Montplaisir, 2011). Parker et al. (2003) 
found that REM and total sleep time was reduced by up to 50% in ESRD patients. Moreover, it 
has been shown that even one night’s sleep loss can impair olfactory performance (Killgore & 
McBride, 2006). While all of these studies have only shown a decline in OI, Stiasny-Kolster et 
al. (2005) found that those with REM sleep disorders to have significantly reduced olfactory 
abilities for OI, DT, and discrimination tasks. 
As stated earlier, depression is also very prevalent in the KD population. Depression has 
actually been under diagnosed in the ESRD population, with only ~14% being diagnosed by a 
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physician although reliable scales of depression depict 43% as having major depressive 
symptoms (Lopes et al., 2004). Olfactory deficits have been found in depression, yet there are 
some discrepancies in the literature (Pantelis & Brewer, 2006). As opposed to KD, there is 
conflicting data regarding the OI abilities, not the DTs. Serby, Larson, and Kalkstein (1990) 
found OI deficits in depressed patients while Amsterdam, Settle, Doty, Abelman, and Winokur 
(1987) and Solomon et al. (1998) found no dysfunction in OI abilities. However, there is a clear 
consensus of a negative relationship between depression and DTs (Negoias et al., 2010; Pause, 
Miranda, Göder, Aldenhoff, & Ferstl, 2001; Pollatos et al., 2007). 
 
The Present Study 
The present study is a small part of a much larger and still ongoing project supported by 
Dialysis Clinics, Inc. (DCI) (Tumlin, 2012). The study as a whole will investigate 
neurotransmitter levels, the safety of a drug supplementation, sleeping patterns and habits, 
quality of life, depression, blood and plasma analyses, and olfactory performance over a two 
month time period for each participant. However, only the olfactory portion will be presented in 
this work.  The present study will address and clarify the discrepancy in the literature by 
obtaining several measures of olfactory ability. Additionally, a new measure for assessing 
olfactory DTs was used in order to improve on the current methodology and to validate its use. 
Lastly, the relationship of additional variables that may be better predictors of olfactory 
performance and KD was assessed. 
The main objective of the present study is to address and clarify the discrepancy in the 
literature. While there are discrepancies in the DT literature for the KD population, there does 
appear to be a trend of poor OI performance. The first hypothesis is: 
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H1: The Kidney Disease participants will have significantly lower  
OI scores compared to the control subjects. 
The methodology in the new olfaction threshold test (the WUTC) will allow for a more 
reliable measure of olfactory DTs. Olfactory performance can vary based on different odorants, 
and the discrepancies in the threshold literature may be a result of using an unreliable or 
irrelevant odorants for the population. Basing the DT measure on scents relevant to the CKD and 
ESRD population should also allow for a greater accountability of variances in detection 
performance between different populations (i.e. ESRD/CKD and control subjects). This 
increased test accuracy leads to the second hypothesis: 
H2: The Kidney Disease participants will have significantly higher  
threshold scores compared to the control subjects. 
Through the use of SDT and the dichotomous response to every stimulus (including 
blanks), it will be possible to obtain actual measures of sensitivity for subjects. Since KD is 
associated with olfactory deficits, they should have a decreased ability to distinguish odorants 
from blanks. Thus, the third hypothesis is: 
H3: The Kidney Disease participants will have significantly lower  
sensitivity scores compared to the control subjects. 
 In addition to the increased reliability from the methods used in the WUTC, the test was 
specifically designed to test olfactory abilities in the CKD and ESRD population. This specificity 
should allow for the test to be used as a diagnostic tool. The fourth hypothesis is: 
H4: The measures of the WUTC will be able to distinguish those with Kidney Disease from the 
controls subjects with high specificity and sensitivity. 
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Also, given the high prevalence of disorders that also affect olfaction in the ESRD and 
CKD population, analyses will be utilized to assess for any possible moderating relationship that 
may account for the varying results. This analysis was conducted by adding covariates into 
regression models to see if any significant predictors of olfactory performance emerged. The 
specific covariates assessed are sleep quality and depression. These variables are important given 
the high prevalence of these disorders in the KD population.
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CHAPTER II
METHODS 
 
 
Participants 
The recruitment of KD participants was supported by DCI and conducted through the 
Southeastern Renal Research Institute (SERRI). Control Subjects were recruited through a 
community sample to be age and gender matched to the KD participants. The inclusion and 
exclusion criteria differed for the KD participants and control subjects who also went through 
slightly different procedures.  
 
Kidney Disease Participants 
Inclusion criteria for the KD population were that participants be between 18 and 85 
years old. Participants also had to be diagnosed with either CKD or ESRD and if undergoing 
dialysis, duration had to be greater than 3 or more months. Participants could also not be on any 
sleep medications. Participants were recruited from the Chattanooga, TN area. There were a total 
of 15 participants recruited, with a total of 8 participants (1 female) completing all requirements 
for participating. Mean age was 56.2 (SD = 11.9) and 75% were African American (n = 6). For a 
full list of inclusion and exclusion criteria, see Appendix A. Demographic information for these 
participants were obtained through medical records. Any individual involved in the collection of 
this data received certifications in the protection of human rights as research participants. 
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Control Participants 
 Control participants were recruited based on characteristics of the KD participants. After 
completion of protocols from KD participants, control subjects were recruited from the same 
geographical area to be age and gender matched. Of the 8 KD participants, only 5 (1 female) 
controls were obtained. Mean age was 54.4 (SD = 11.8, not significantly different from KD 
participants) and 20% (n = 1) were African American. Controls were also matched based on 
ethnicity. The discrepancies in the numbers were a result of a KD participant being excluded 
from the current study as a result of incomplete olfactory data. Demographic information for the 
control subjects was obtained through a demographic questionnaire. The questionnaire asked 
participants to indicate age, gender, ethnicity, occupation, etc. It also asked participants to 
indicate any history of specific illnesses and medication use in order to further match the KD 
participants (See Appendix B for the complete demographics).  
 
Materials 
 Materials include: the University of Pennsylvania Smell Identification Test (UPSIT) 
(Doty et al., 1984), the WUTC (Tewalt, 2013), the Center for Epidemiologic Studies Depression 
– Revised Scale (CESD-R) (Eaton, Smith, Ybarra, Muntaner, & Tien, 2004), and the Pittsburg 
Sleep Quality Index (PSQI) (Buysse, Reynolds III, Monk, Berman, & Kupfer, 1989). These 
materials can be found in Appendices C, D, E, and F, respectively. 
 
University of Pennsylvania Smell Identification Test 
 The UPSIT is a 40 item test consisting of four booklets. Each booklet contains 10 
different odorants located on separate pages with 4 possible choices to choose from for each 
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odorant. The participants were instructed to use the pencil provided to scratch and release an 
odorant and try to identify the odorant by selecting one of the provided choices as per the 
instruction manual (Doty, 1995). A forced choice test, for the test to be valid each item must be 
answered. If the participant does not detect an odorant or the choices do not represent what the 
participant believes the odorant to be, they must still pick one of the choices. Each test booklet 
and its odorants were presented to each participant in the same order. The participant score was 
based on the percentage of correct responses (See Appendix C for UPSIT Key). 
 
Wheeler University of Tennessee at Chattanooga Threshold Test 
The WUTC consists of 54 tubes with nine different dilutions for five odorants and 
blanks. Each tube contains 10ml of the odorant dilution or blank. The presentation of the tubes is 
double blind, requiring two people to administer the test. One person was responsible for 
recording responses and handing the tubes based on a randomized sequence sheet to the 
presenting researcher. See Appendix D for a picture of the test and an example sequence sheet. 
The odorants are Vanillin, L-α-Pinene, Ethanol, Isoamyl Acetate (Banana), and P-cresol. The 
dilutions are made so the middle dilution coincides with detection threshold norms and are a 
clear liquid. The blanks contain 10ml of purified distilled water. The tubes are presented to each 
individual in a completely random order and each tube is presented for a total of two times. 
Responses of, “yes,” for being able to detect the odorant and, “no,” for not being able to detect 
the odorant were recorded for each tube presentation. An analysis using Logistic Regression was 
used to obtain the projected threshold for each participant. If any B coefficient is negative, then 
threshold cannot be computed as a result of response confusion. 
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Measures of sensitivity were also obtained from the WUTC. Values for the non-
parametric measure A’’ were obtained by taking the proportion of detections in all stimuli that 
contained odorants and the proportion on “yes” responses to blanks. These values were then 
calculated using equation 1.2 to obtain an overall sensitivity measure. Since values less than .5 
indicate some type of response confusion or sampling error, any participant whose A’’ <.05 was 
omitted from analyses. Moreover, measures of A’’ were also calculated for each individual 
odorant. 
 
Center for Epidemiologic Studies Depression – Revised Scale 
In order to obtain depression scores, the CESD-R was used. It is designed to measure 
depression based on the 4
th
 edition of the Diagnostic Statistical Manual (DSM-IV) and has been 
shown to have high reliability (Eaton et al., 2004). This measure consists of 20 items using a 4 
point Likert scale (0-3) asking participants to rate his or her feelings during the past week. The 
final depression scores is a summation of the 20 items resulting in a range of scores from 0 to 60. 
A higher score indicates greater depression. Scores 16 and over are indicative of being clinically 
depressed and is used as a diagnostic cut off. See Appendix E for the complete CESD-R. 
 
Pittsburg Sleep Quality Index 
The PSQI is a 19 item self-report measure for assessing sleep quality and disturbances in 
the past month. Four of the items ask for open ended responses such, “How many hours of actual 
sleep do you get at night?” The rest of the items are rated on a 4 point Likert Scale (0-3). The 
open ended items were recoded into a 0-3 scale. These recodes were made according to the 
scoring instructions. The PSQI is broken up into 7 components, each with instructions for 
22 
scoring based on the responses from the 19 items. Scores can range from 0 to 21 with higher 
scores indicating poor sleep. Scores 5 and higher are typically indicative of poor sleep. See 
Appendix F for the full PSQI. Specific scoring instructions can be found through Buysse et al. 
(1989). 
 
Procedure 
 All data collected was managed and analyzed using the IBM Statistical Package for the 
Social Sciences (SPSS). No personal identifying information was entered into these files, and all 
data files were kept on an encrypted hard drive to further protect personal information. The 
following procedures were approved by the Institutional Review Board (See Appendix G for the 
Kidney Disease IRB Approval Letter and Appendix H for the Control IRB Approval Letter) 
 
Kidney Disease Procedure 
 Upon giving consent for the larger study, KD participants were scheduled to come into a 
research facility for a morning and afternoon appointment. If the participant was on dialysis, the 
scheduled appointments fell on a non-dialysis days. During each of the times, protocols for the 
blood analysis investigation which was part of the larger study would be implemented. After 
completing this necessary aspect of the study which also included the PSQI, participants were 
brought into a room and were given a battery of psychometric tests for this study which included 
the CESD-R, UPSIT, and WUTC. Participants first completed the CESD-R. Detailed 
instructions were given to each participant verbally, as well as having written instructions at the 
top of every page. After completing the questionnaire packet, participants were given the first 
booklet from the UPSIT. Verbal instructions were given based on the instructions attached with 
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the UPSIT. Subsequent booklets were given after completing the previous one. Lastly, the 
WUTC was administered. Since the WUTC is a double blind administration, the participant was 
seated facing away from the researchers. One researcher was responsible for presenting the tube 
to the participant, while the other pulled tubes based on the randomized sequence sheet. 
Participants were instructed that some of the tubes contained an odorant while others did not and 
the ones that do contain odorants have varying amounts. Participants were then instructed they 
had 3-5 seconds to smell the tube and to then respond with whether or not they detected an 
odorant. After completing the WUTC, participants were free to leave.  
Since the KD participants were also participating in the larger study, they were not 
debriefed as to the nature of the study or given results of their performance. This was done to 
prevent any future response bias in the follow up examinations when the procedure is replicated. 
 
Control Subject Procedure 
The protocol for the controls was matched as much as possible to the KD procedure. 
After recruitment, participants were brought to a local university. Upon arriving, consent was 
first obtained from participants (See Appendix I). Next, the controls took the same battery of 
psychometric tests as the KD participants did with the addition of the demographic 
questionnaire. The same verbal and written instructions were given for completing the 
questionnaires and olfactory measures. When administering the WUTC, controls were set up in a 
similar fashion as the KD participants. 
The procedure differed for the controls in that they were debriefed about the purpose of 
the study. There was no need to prevent any future response bias as controls participated in only 
one session. 
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Statistical Analyses 
An independent samples t test was used to analyze the hypotheses regarding poorer 
olfactory performance in the KD participants compared to the controls. The t test was also used 
to compare age between the two groups. In order to obtain thresholds for each participant, a 
logistic regression analysis was used. This analysis allowed for predicted probabilities to be 
saved for each concentration. A graph was then created with the concentrations on the x-axis and 
probabilities on the y-axis for each participant. An ogival curve was then plotted through points 
on the graph and a horizontal line was added at .5 on the y-axis. A vertical line was then placed 
at the intersection of the ogival curve and horizontal line. Where the horizontal line fell on the x-
axis was determined to be the estimated threshold. See Figure 1.1 for the graphical 
representation. Logistic regression was also used to assess the significance of variables in 
predicting KD.
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CHAPTER IV
RESULTS
 
 
Group Comparisons 
Although there was not a control for every KD participant, there was no significant 
difference in ages between the two groups (t(11) = -.328, p = .749). Table 3.1 below shows the 
group means for age as well as provides a comparison of genders and ethnicities. Table 3.2 
shows group means and standard deviations for each of the olfactory measures excluding DTs. 
Table 3.3 illustrates the differences between KD and controls in mean thresholds for each 
odorant. 
 
Table 3.1 Comparative Means of Age and Percentage of Demographics between KD and 
Control Subjects 
 Standard Deviations are in parentheses 
Group Age Males Females Caucasian 
African 
American 
Kidney 
Disease 
56.2 
(11.9) 
87.5% 12.5% 25.0% 75.0% 
No Kidney 
Disease 
54.4 
(11.8) 
80.0% 20.0% 80.0% 20.0% 
 
  
26 
Olfactory Identifications 
The first hypothesis was that KD participants would have lower OI scores compared to 
the controls. The hypothesis was not supported (t (11) = 1.395, p = .191). However, average OI 
scores for KD participants were lower compared to the controls. See Table 3.2.  
Detection Thresholds 
The second hypothesis was not supported either. Results for all odorants indicate that 
none of the thresholds are significantly higher than the controls. The corresponding results for 
Vanillin, Pinene, Ethanol, Banana, and P-Cresol are t (7) = -.243., p = .815, t (6) = -.919, p = 
.394, t (7) = -.891, p = .403, t (8) = -.589, p = .572, and t (3) = -.769, p = .498, respectively. 
Although the results showed no significant differences between KD and control DTs, the KD 
thresholds were higher for all odorants. 
 
Sensitivity 
Sensitivity was hypothesized to be lower for KD participants, indicating that they would 
have a harder time distinguishing odorants from blanks compared to the controls. Similar to the 
analysis for the first hypothesis, the t test again did not reach significance (t (9) = 1.239, p = 
.247) despite the fact that sensitivity scores were lower than the controls (with the exception of 
vanilla). Further group comparisons were made for each odorant sensitivity, but nothing 
significant was found, although sensitivity of P-Cresol approached significantly lower scores for 
KD participants (t (9) = 2.225, p =.053). 
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Table 3.2 Comparative Means of OI and Sensitivity between KD and Control Subjects 
 Standard Deviations are in parentheses 
Group OI 
Overall 
A’’ 
Vanillin 
A’’ 
Pinene 
A’’ 
Ethanol 
A’’ 
Banana 
A’’ 
P-Cresol 
A’’ 
Kidney 
Disease 
.70 
(.18) 
.67 
(.08) 
.77 
(.06) 
.57 
(.21) 
.53 
(.15) 
.75 
(.10) 
.61 
(.21) 
No 
Kidney 
Disease 
.82 
(.12) 
.74 
(.11) 
.73 
(.18) 
.70 
(.10) 
.66 
(.15) 
.81 
(.07) 
.84 
(.06) 
 
 
 
Table 3.3 Comparative Means of DT for Each Odorant between KD and Control Subjects 
Concentration Ranges in parts per million are below odorant name. Standard 
Deviations are in parentheses 
Group 
Vanillin 
1.95-500.00 
Pinene 
7.81-2000.00 
Ethanol  
3.91-1000.00 
Banana 
.48-125.00 
P-Cresol 
.03-8.00 
Kidney 
Disease 
51.56 
(43.72) 
1273.27 
(2102.58) 
1245.60 
(2084.01) 
10.29 
(21.03) 
3.16 
(5.21) 
No Kidney 
Disease 
41.24 
(82.49) 
282.52 
(482.23) 
279.07 
(558.15) 
2.86 
(2.50) 
0.17 
(0.18) 
 
 
 
Prediction of Kidney Disease 
 
 None of the measures were significant predictors, nor were any combinations of olfactory 
measures and/or disorders.
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CHAPTER V
DISCUSSION AND CONCLUSION 
 
 
Implications of Results 
 None of the hypotheses were supported by the data analyses. With the exception of 
sensitivity to Vanillin, the KD participants performed worse than the controls on all olfactory 
measures. Although the prior evidence supported an olfactory deficit in identification abilities 
(Corwin, 1989; Raff et al., 2008), the current statistical analyses did not reach  significance. The 
results from this study do not necessarily mean that these previous studies are not supported, but 
instead suggest deficiencies in the current procedure. 
The main factor affecting the results is the amount of variance in each olfactory measure. 
The only way for the variance in the data to be reduced is by including more participants. 
Additionally, there are still too few participants for a representative sample of the population as 
whole. Tables 3.1 and 3.2 indicate that this is especially true for DTs; the standard deviations 
actually exceed the means and far surpass the differences between the groups. Once enough 
participants have been added to generate a high enough statistical power, it may be possible to 
see the trends of poorer performance become significant differences. 
Even though there was no significant difference in DTs between the two groups, there too 
appears a trend of poorer performance on this task. Every single odorant used indicated higher 
thresholds for the KD participants. Further analyses showed an interesting factor affecting 
performance for both KD and controls. The factors distorting the results are both a floor and 
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ceiling effect. This effect is seen separately for the different groups. Control performance 
appears to be influenced by a floor effect, while the KD participants are affected by a ceiling 
effect. It was discovered that on average, there was not a stimulus with a low enough 
concentration to be undetectable for the controls. These floor effects were present for the 
controls on Vanillin and Ethanol. Figures 4.1 and 4.2 are graphs that show the relationship of the 
average predicted probabilities for each group based on the concentration.  
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Figure 4.1 Predicted Probability Curve of Vanillin by Group with Evidence of a Floor Effect 
in Control Groups 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added 
for each group. The horizontal line depicts where the probability of .5 would intersect the 
probability curve. The corresponding concentration at the intersection of the horizontal line and 
probability curve is the estimated threshold. The floor effect is present for the controls given the 
predicted probability never drops below .5. 
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Figure 4.2 Predicted Probability Curve of Vanillin by Group with Evidence of a Floor Effect 
in Control Groups 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added 
for each group. The horizontal line depicts where the probability of .5 would intersect the 
probability curve. The corresponding concentration at the intersection of the horizontal line and 
probability curve is the estimated threshold. The floor effect is present for the controls given the 
predicted probability never drops below .5. 
 
 
On the other end of the spectrum, there was no concentration strong enough for KD 
participants to detect on average. For example, Table 3.2 in the previous section shows the 
average threshold for Ethanol higher than the range that was tested. This occurred as a result of 
three separate KD participants having their threshold calculated by extrapolating the graph 
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beyond the thresholds measured. That is, the predicted probabilities never cross the .5 probability 
line for the range of concentrations tested, indicating the presence of a ceiling effect. For those 
three participants, this effect occurred on every odorant except Banana.  
Despite not having a concentration low enough to measure thresholds for the controls 
(thus giving them a threshold concentration of .0) and not having concentrations high enough for 
KD participant to detect, there was still no significant difference between groups for these 
thresholds. Variance in the thresholds as a result of the small sample size may also be preventing 
any significant results from occurring. 
As a result of the small sample size, the inferential statistics may not be the best tool to 
use assessing the different in DTs between diseases. The following graphs (Figures 4.3 – 4.5) 
show the average predicted probability curves for all participants by odorant.  
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Figure 4.3 Predicted Probability Curve of Pinene by Group 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added 
for each group. The horizontal line depicts where the probability of .5 would intersect the 
probability curve. The corresponding concentration at the intersection of the horizontal line and 
probability curve is the estimated threshold. 
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Figure 4.4 Predicted Probability Curve of Banana by Group 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added 
for each group. The horizontal line depicts where the probability of .5 would intersect the 
probability curve. The corresponding concentration at the intersection of the horizontal line and 
probability curve is the estimated threshold. 
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Figure 4.5 Predicted Probability Curve of p-Cresol by Group 
The horizontal scale is graphed using a logarithmic scale to avoid skewness. Each point on the 
graph represents the probability of that concentration being detected with an ogival curve added 
for each group. The horizontal line depicts where the probability of .5 would intersect the 
probability curve. The corresponding concentration at the intersection of the horizontal line and 
probability curve is the estimated threshold. 
 
 
 
 As seen in the above figures (Figures 4.1 – 4.5), there appears to be performance 
differences based on odorant. It appears that there are very little differences in thresholds for KD 
participants compared to the controls in Pinene and Banana. However, there are large differences 
for the odorants Vanillin and Ethanol. The WUTC did not have a concentration low enough for 
the controls to detect on either odorant. Additionally, the WUTC did not contain a concentration 
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high enough for KD participants to detect. While no floor or ceiling effect was found for p-
Cresol, the comparison of probability curves does appear to show poorer detection abilities for 
KD participants. This difference may also not be statistically significant as a result of the 
variability in the data. However, if significance is attained through a larger sample size, the 
decrease in DT for P-Cresol may be a result of some biological mechanism used in olfaction 
being blocked from the buildup of uremic toxins found in KD (McKinney, 2013) and may 
explain why the differences in sensitivity of P-Cresol were so close to significant in the small 
sample size. Another explanation for this difference in sensitivity may be a result of the KD 
participants being habituated to the odorant. Voss et al. (2005) found that KD patients do not 
smell their uremic odorant and their sweat contained high levels of uremic concentrations.  
 
Limitations 
 As already discussed, the major limitation to the study was sample size. The criterion to 
meet in order to be eligible is a very long and specific list (See Appendix A for full list). This 
also made it very difficult for the recruitment of controls. Since controls had to be age and 
gender matched, recruitment could not be started until KD participants completed their 
participation. Further complicating this limitation was a result of having to omit participants 
from the already small dataset as a result of test performance. As stated in the introduction, any 
value of A’ ≤ .5 is due to an error in response confusion. Two individuals, one in each group, 
were removed from the analyses as a result of small A’ values. Their A’ values were indicative 
that these participants were guessing through the entire testing procedure. The guessing may 
have resulted from a total lack of olfactory ability. 
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 B coefficients were obtained for every threshold analysis. Some coefficients were 
negative, indicating a decrease in predicted probability for detecting odorants as the 
concentrations increased. Anyone with an estimation of threshold with a negative B coefficient 
was not included in the analyses. The negative coefficients can actually be used for 
determinations of response confusion or possible guessing for participants. Surprisingly, this was 
only observed in the KD participants. No individual threshold was excluded from the controls as 
a result of response confusion. Given that response confusion was only found in KD participants, 
it may be indicative of an olfactory deficit.   
 However, there were a number of thresholds that were not able to be computed for the 
controls. These thresholds could not be obtained as a result of responding yes to every stimulus 
for an odorant. The logistic regression analysis will not compute predicted probabilities without 
the dependent variable assuming exactly two variables. This issue was only seen in the controls. 
This could be a result of response bias. Controls did have a higher response bias, indicating a 
higher tendency to say yes compared to the KD participants (B’’ = .194, B’’ = -.346, 
respectively). The non-significant difference in response bias could be the result of the small 
sample size, but it is more likely a result from the ranges used on the WUTC. 
 Another possible issue resulting from the small sample size is reliability. While Tewalt 
(2013) found reliability measures of > .8, the highest reliability observed in the present study was 
K = .644 (See table 4.1 for all observed reliability measures for each odorant). The reliability 
coefficient used was K to check for agreement in detection or no detection from the first 
presentation of a stimulus to its second presentation. Scores can range from -1 (no agreement) to 
+1 (high agreement). 
  
38 
Table 4.1 Observed Reliability Coefficients of the WUTC 
Odorant Overall KD Controls 
Vanillin .592 .581 .573 
Pinene .501 .335 .644 
Ethanol .449 .362 .429 
Banana .550 .524 .493 
p-Cresol .535 .377 .552 
 
  
A statistically significant difference may not have been found as a result of the WUTC 
design. Although the WUTC includes the middle concentration reflective of the normative data 
on each odorant’s threshold (Tewalt, 2013), the range may have been too restricted for the 
samples or populations being tested. The design of the test is restricting the range of sensitivity 
in that only half of the odorant containing stimuli is supposed to be detected. This restricted 
range may have also been a major cause in creating the ceiling and floor effects observed in the 
participants.  
 
Direction of Future Research 
 The present study is a part of a much larger clinical drug trial that is still ongoing. The 
continuation of the study should alleviate the small sample size and reduce the variance. 
Olfactory measures may start to differentiate between KD participants and controls. Once the 
variance issue has been resolved, the analyses may become significant, given the trend of poorer 
olfactory performance in the KD participants. The larger study of which this study was a subset 
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of is also assessing the effectiveness of a drug supplementation which could be used to examine 
possible treatment effects like those seen in Landis et al. (2011) and Griep et al. (1997). 
 Adjusting the range of the odorants used in the WUTC is also necessary to analyze 
thresholds in both KD and control subjects. Extending the range of the concentrations may 
alleviate the presence of the ceiling and floor effects. One recommendation is to exclude two of 
the odorants currently in the WUTC. No ceiling or floor effects were found for Pinene or 
Banana, nor was there any indication of an obvious difference in probability curves. By 
eliminating these two odorants, the ranges can be extended three concentrations in each direction 
without adding to the length of the test. By extending the range and increasing the sample size, it 
may be possible to predict KD based on olfactory performance. 
 In addition to extending the ranges of concentrations in the WUTC, there should be a 
standardization of odorants used in testing olfactory performance in the KD population. Table 
4.1 shows the results of previous studies and the odorants that were used when examining 
olfactory abilities in the KD population.  
  
40 
Table 4.2 Comparison of Results from Previous Olfactory Assessments of KD when 
Compared to Controls 
 OI tests used and the odorant(s) used in the study are reported in the parentheses. 
Study Olfactory Identification Detection Thresholds 
The Present Study 
Non-significantly Lower 
(UPSIT) 
Non-Significantly Higher 
(Vanillin, Pinene, Ethanol, 
Isoamyl Acetate, p-Cresol) 
Landis et al. (2011) 
Significantly Lower (Sniffin’ 
Sticks) 
Normal (n-Butanol) 
Elevated (Acetic Acid) 
Frasnelli et al. (2002) 
Significantly Lower (Sniffin’ 
Sticks) 
Normal (n-Butanol) 
Griep et al. (1997) - 
Significantly Higher (Isoamyl 
Acetate) 
Korytowska and Szmeja 
(1993) 
Significantly Lower (Coffee 
and Lemon) 
Normal (Coffee, Lemon Oil) 
 
 
Only two odorants were used in more than one study, n-Butanol and Isoamyl Acetate, 
both of which have a banana smell. The reason the mixed results have been found in the DT 
literature may be a result of not using an odorant or odorants that are affected by the symptoms 
of the disease, like levels of uremic toxins in the blood. 
 Given the differences found with P-Cresol, both in sensitivity and thresholds, blood 
analyses should be done to determine if there is a relationship between P-Cresol blood levels and 
olfactory performance. McKinney (2013) found there was no P-Cresol in healthy individuals, 
which means P-Cresol may be the cause for the olfactory deficits. If there is an indication of a 
negative relationship, then further analyses can assess why P-Cresol may be hindering olfactory 
performance. 
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Conclusion 
 There has been conflicting data in regards to olfactory performance in KD. While there is 
a trend for deficits in OI, the results for DT are inconsistent. The prior results indicate poorer 
performance, no difference in performance, or varied performance between odorants when 
compared to healthy individuals. Further complicating the relationship of olfaction and KD is the 
increased prevalence of sleep disorders and depression. Both of these disorders have also been 
linked to declines in olfactory performance. 
Although there were no statistically significant differences found in olfactory abilities 
between KD participants and controls, there does appear to be a trend for poorer olfactory 
abilities.  The difference observed may not have been found significant as a result of the small 
sample size or as a result of the floor and ceiling effects found. Furthermore, the small sample 
size and large amount of variance may also have prevented any significant predictors of olfactory 
abilities and KD from being found.
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INCLUSION AND EXCLUSION CRITERIA FOR KIDNEY DISEASE 
PARTICIPANTS 
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INCLUSION/EXCLUSION CRITERIA:    
 
Inclusion Criteria: 
1) Patient age > 18 and <85 years of age 
2) Patients with CKD  or ESRD with eGFR < 30 mls/min 
3) If receiving hemodialysis, patients must be on treatment > 3 months 
4) Normal healthy controls must be without a known history of CKD and be willing to 
have formal PSG test and plasma melatonin measurements 
 
Exclusion Criteria: 
1) Patients receiving outpatient hemodialysis for < 3 months 
2) Patients with estimated GFR by Cockcroft Gault > 30 mls/min 
3) Patients receiving beta blocker therapy within one month of randomization 
4) Patients receiving Nifedipine therapy within one month randomization 
5) Patients on peritoneal dialysis 
6) Patient with chronic home oxygen supplementation 
7) Patients receiving chronic home CPAP therapy 
8) Patients actively receiving outpatient sleep medications 
9) Patients with diabetic gastroparesis unresponsive to medication 
10) Patients with known pregnancy or unwilling to use contraception during the course of 
the study 
11) Patients with a functioning renal allograft 
12) Patient currently receiving long-term immunosuppressive therapy.  Patients receiving 
low dose prednisone (10mg or less per day) will not be excluded from this trial 
13) Unable to give informed consent 
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Age (in years): _________ 
Gender (circle one); Male Female 
If female, please answer the questions located on the next page. *** 
Ethnicity (circle one): Caucasian African American Asian American Hispanic 
Bi-Racial  Other (please indicate): _______________________________ 
Do you currently smoke (circle one):      Yes No 
If yes; How many cigarettes per day?_____; Cigars per day?____ 
What type of cigarettes do you smoke? __________________________ 
How many years have you smoked? ______________ 
If not currently smoking, have you ever smoked? (Circle one):   Yes No 
If yes, how long ago did you stop?_______ 
How many cigarettes did you smoke per day?_____;  Cigars per day?_____ 
Did your ability to smell change after you stopped smoking? (Circle one): Yes No 
If yes; How? 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
 
What is your occupation: ____________________________________________________ 
Highest grade completed? (Circle only one number): 
6 7 8 9 10 11 12   College   1     2  3  4  5 + 
Please indicate if you have had past history of the following medical Illnesses. (Circle Yes or No): 
High blood pressure  Yes No  Diabetes  Yes No 
Arthritis   Yes No  Heart disease  Yes No 
Thyroid disorder  Yes No  Headaches  Yes No 
Lung trouble   Yes No  Gout   Yes No 
Epilepsy   Yes No  Circulation problems Yes No 
Broken nose   Yes No  Anemia   Yes No 
Strokes    Yes No  Eye problems  Yes No 
Asthma    Yes No  Cancer   Yes No 
52 
Please indicate if you have had past history of the following medical Illnesses. (Circle Yes or No): 
Hepatitis   Yes No  Ulcer   Yes No 
Hiatal hernia   Yes No  Kidney disease  Yes No 
Pelvic disease   Yes No  Skin disease  Yes No 
Prostate problems  Yes No  Infections  Yes No 
Bleeding/clotting disorder Yes No  HIV   Yes No 
TB    Yes No  Neurological disease Yes No 
Deviated septum  Yes No  Sinus problems  Yes No 
Concussion/head trauma Yes No  Medical allergies Yes No 
Food allergies   Yes No  Seasonal allergies Yes No 
Other: _______________________________________________________________________________ 
Please indicate if you are currently taking any of the following types of medications. (Circle Yes or 
No): 
Antibiotics   Yes No  Antidepressants  Yes No 
Hormone replacements  Yes No  Antihistamines  Yes No 
Antihypertensive  Yes No  Antianxiety  Yes No 
Lithium   Yes No 
Anti-inflammatory
†
  Yes No 
†
Including ibuprofen 
Antineoplastic
††
  Yes No 
††
Examples of Antineoplastics are Elspar (asparaginase), Alkeran (melphalan), floxuridine, 
lomustine, procarbazine, thioguanine, thiotepa 
Stimulant medications
†††
 Yes No 
†††
Examples of Stimulant medications are Adderall and Vyvanse  
Have you ever been diagnosed with Sleep Apnea? (Circle one):    Yes No 
***Females (optional, But VERY BENEFICIAL to answering research questions) 
If FEMALE; Are you currently on your menstrual cycle? (Circle one):   Yes  No 
If FEMALE; Are you currently pregnant? (Circle one):     Yes No 
If FEMALE; Are you in menopause or post menopause? (Circle one):  Yes No
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UNIVERSITY OF PENNSYLVANIA SMELL 
IDENTIFICATION KEY 
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UPSIT Key 
1. B – Pizza 
2. B – Bubble Gum 
3. D – Menthol 
4. D – Cherry 
5. C – Motor Oil 
6. B – Mint 
7. A – Banana 
8. B – Clove 
9. C – Leather 
10. B – Coconut 
11. C – Onion 
12. B – Fruit Punch 
13. A – Licorice 
14. D – Cheddar Cheese 
15. B – Cinnamon 
16. D – Gasoline 
17. A – Strawberry 
18. A – Cedar 
19. B – Chocolate 
20. C – Gingerbread 
 
 
21. A – Lilac 
22. A – Turpentine 
23. B – Peach 
24. A – Root Beer 
25. B – Dill Pickle 
26. C – Pineapple 
27. D – Lime 
28. B – Orange 
29. B – Wintergreen 
30. D – Watermelon  
31. D – Paint Thinner 
32. C – Grass 
33. C – Smoke 
34. A – Pine 
35. D – Grape 
36. D – Lemon 
37. A – Soap 
38. D – Natural Gas 
39. B – Rose 
40. A – Peanut
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WUTC EXAMPLE SEQUENCE SHEET 
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Melatonin Threshold Name:___________________________ Date: ____________ 
Sequence/Response 
Sheet 
     
  
Admin: ______________________ 
Record: 
____________________ 
       Sequence Remaining 
  
Answer yes=1, no=0 
       
    
First time | Second time 
6 
   
[1] | [55] 
39 
   
[2] | [56] 
43 
   
[3] | [57] 
50 
   
[4] | [58] 
35 
   
[5] | [59] 
48 
   
[6] | [60] 
10 
   
[7] | [61] 
31 
   
[8] | [62] 
44 100 
  
[9] | [63] 
34 
   
[10] | [64] 
5 
   
[11] | [65] 
41 
   
[12] | [66] 
16 
   
[13] | [67] 
22 
   
[14] | [68] 
51 
   
[15] | [69] 
52 
   
[16] | [70] 
47 
   
[17] | [71] 
40 
   
[18] | [72] 
46 90 
  
[19] | [73] 
11 
   
[20] | [74] 
32 
   
[21] | [75] 
42 
   
[22] | [76] 
36 
   
[23] | [77] 
20 
   
[24] | [78] 
22 
   
[25] | [79] 
53 
   
[26] | [80] 
25 
   
[27] | [81] 
25 
   
[28] | [82] 
14 80 
  
[29] | [83] 
1 
   
[30] | [84] 
1 
   
[31] | [85] 
57 
49 
   
[32] | [86] 
6 
   
[33] | [87] 
48 
   
[34] | [88] 
11 
   
[35] | [89] 
52 
   
[36] | [90] 
51 
   
[37] | [91] 
54 
   
[38] | [92] 
20 70 
  
[39] | [93] 
29 
   
[40] | [94] 
45 
   
[41] | [95] 
26 
   
[42] | [96] 
26 
   
[43] | [97] 
10 
   
[44] | [98] 
18 
   
[45] | [99] 
4 
   
[46] | [100] 
13 
   
[47] | [101] 
19 
   
[48] | [102] 
54 60 
  
[49] | [103] 
7 
   
[50] | [104] 
15 
   
[51] | [105] 
35 
   
[52] | [106] 
53 
   
[53] | [107] 
2 
   
[54] | [108] 
9 54 
     15 
      30 
      2 
      33 50 
     21 
      12 
      4 
      12 
      38 
      27 
      24 
      23 
      9 
      38 40 
     41 
      
58 
3 
      8 
      39 
      28 
      45 
      36 
      19 
      7 
      3 30 
     44 
      50 
      28 
      24 
      33 
      5 
      42 
      27 
      31 
      29 20 
     14 
      43 
      23 
      13 
      16 
      17 
      17 
      49 
      30 
      40 10 
     8 
      18 
      37 
      46 
      32 
      21 
      47 
      34 
      37 
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CENTER FOR EPIDEMIOLOGIC STUDIES 
DEPRESSION – REVISED SCALE 
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Place a check mark or “X” in the appropriate box. Only select one for each question. 
Below is a list of the ways you might 
have felt or behaved.  Please check 
the boxes to tell me how often you 
have felt this way in the past week or 
so. 
Last Week 
Nearly 
every 
day for 2 
weeks 
Not at all 
or Less 
than 1 
day 
1-2 days 3-4 days 5-7 days 
1) My appetite was poor. 
     
2) I could not shake the blues. 
     
3) I had trouble keeping my 
mind on what I was doing. 
     
4) I felt depressed. 
     
5) My sleep was restless. 
     
6) I felt sad. 
     
7) I could not get going. 
     
8) Nothing made me happy. 
     
9) I felt like a bad person. 
     
10) I lost interest in my usual 
activities. 
     
11) I slept much more than 
usual.  
     
12) I felt that I was moving too 
slowly. 
     
13) I felt fidgety. 
     
14) I wished I were dead. 
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Place a check mark or “X” in the appropriate box. Only select one for each question. 
Below is a list of the ways you might 
have felt or behaved.  Please check 
the boxes to tell me how often you 
have felt this way in the past week or 
so. 
Last Week 
Nearly 
every 
day for 2 
weeks 
Not at all 
or Less 
than 1 
day 
1-2 days 3-4 days 5-7 days 
15) I wanted to hurt myself. 
     
16) I was tired all the time. 
     
17) I did not like myself. 
     
18) I lost a lot of weight 
without trying to. 
     
19) I had a lot of trouble 
getting to sleep. 
     
20) I could not focus on the 
important things. 
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PITTSBURG SLEEP QUALITY INDEX 
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During the past month, 
1. When have you usually gone to bed (what time)? _________________ 
2. How long (in minutes) has it taken you to fall asleep each night? ________________ 
3. When have you usually gotten up in the morning? ____________________ 
4. How many hours of actual sleep do you get at night? (This may be different than the number 
of hours you spend in bed) _________________ 
5. During the past month, how often have you had 
trouble sleeping because you… 
Not 
during 
the past 
month 
Less 
than 
once a 
week 
Once or 
twice a 
week 
Three or 
more 
time a 
week 
a. Cannot get to sleep within 30 minutes     
b. Wake up in the middle of the night or early 
morning 
    
c. Have to get up to use the bathroom     
d. Cannot breathe comfortably     
e. Cough or snore loud     
f. Feel too cold     
g. Feel too hot     
h. Have bad dreams     
i. Have pain     
j. Other reason(s), please describe, including how 
often you have trouble sleeping because of this 
reason(s): 
    
6. During the past month, how often have you taken 
medicine (prescribed or “over the counter”) to help 
you sleep? 
    
7. During the past month, how often have you had 
trouble staying awake while driving, eating meals, or 
engaging in social activity 
    
8. During the past month, how much of a problem has it 
been for you to keep your enthusiasm to get things 
done? 
    
 
 Very 
Good 
Fairly 
Good 
Fairly 
Bad 
Very 
Bad 
9. During the past month, how would you rate your 
sleep quality overall? 
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MEMORANDUM 
    
 
 
TO:   Dr. Nicky Ozbek        IRB # 12-196 
  Dr. James Tumlin 
   
  
FROM:  Lindsay Pardue, Director of Research Integrity 
  Dr Bart Weathington, IRB Committee Chair  
 
DATE:  November 28, 2012 
 
 
SUBJECT: IRB Application # 12-196: Olfactory Sensitivity and Depression in Dialysis Patients                        
 
The IRB Committee Chair has reviewed and approved your application and assigned you the IRB number 
listed above.  You must include the following approval statement on research materials seen by 
participants and used in research reports: 
 
The Institutional Review Board of the University of Tennessee at Chattanooga (FWA00004149) has 
approved this research project # 12-196. 
 
Since your project has been deemed exempt, there is no further action needed on this proposal unless 
there is a significant change in the project that would require a new review.  Changes that affect risk to 
human subjects would necessitate a new application to the IRB committee immediately.   
 
Please remember to contact the IRB Committee immediately and submit a new project proposal for 
review if significant changes occur in your research design or in any instruments used in conducting the 
study. You should also contact the IRB Committee immediately if you encounter any adverse effects 
during your project that pose a risk to your subjects. 
 
For any additional information, please consult our web page http://www.utc.edu/irb or email us at: 
instrb@utc.edu . 
 
Best wishes for a successful research project. 
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INFORMED CONSENT FOR HEALTHY CONTROLS 
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Informed Consent Form 
While we hope that you will complete the attached study, your participation is voluntary. You 
may elect not to participate at any time. In addition, if you do not feel comfortable answering any 
of the questions you may leave that question blank and continue with the rest of the study. The 
information you provide will be anonymous and we do not ask you to identify yourself in any 
way. Emotional and/or Psychological Stress, Boredom, Nasal Dryness, and/or an Allergic 
Reaction are possible risks associated with your participation in this project. You will not receive 
any direct benefit from participating in the study.  
This first part of the study will ask you to respond to questions about sleeping, general health, 
and recent feelings or behaviors. The second part of the study will ask you to identify smells 
located on scratch and sniff booklets. The third part will ask you to respond whether or not you 
detected an odor in a tube. The last thing the study asks you to do is fill out a demographic page. 
The demographic information will ask about age, gender, ethnicity, occupation, education, 
smoking habits, and specific medical illnesses and medications. These questions will help us to 
interpret the results of the rest of the study. 
The researcher will ask you for any allergies you may have. Depending on your allergies, you 
may be excluded from participating. If an allergic reaction does occur, you will be taken to the 
University Health Services for an allergy shot. 
Some questions may cause emotional or psychological distress. If you experience either type of 
distress, please contact the University Counseling Center. They can be reached by phone or on 
site during walk-in hours. 
Phone: 423-425-4438 
Walk-in Hours: Monday – Friday, 9:00am-11:30am and 1:00pm-3:30pm 
We expect that it will take approximately 1 hour to participate in this study.  
Remember, this is an anonymous survey, so please do not write your name anywhere other than 
this page. You may also request a copy of this form for your records. 
Who to Contact 
If you have any questions or would like to obtain a report of this research study when the results 
have been completed, please contact Dr. Nicky Ozbek (423-425-4262), Department of 
Psychology, University of Tennessee at Chattanooga.  This survey is being conducted as part of 
a Graduate Thesis.  This project meets the requirements for approval by the UTC IRB and 
contact can be made to the UTC IRB through Director Lindsay Pardue (423-425-4443) and Chair 
Dr. Bart Weathington (423-425-4289). 
By signing the consent, you are indicating that you are at least 18 years of age. 
Thank you for participating in our research! 
Name (Print) _____________________________________________ Date________________ 
 
Signature ________________________________________________ Date________________
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